Literature DB >> 3365365

Asymmetry of tyrosyl-tRNA synthetase in solution.

W H Ward1, A R Fersht.   

Abstract

The tyrosyl-tRNA synthetase from Bacillus stearothermophilus crystallizes as a symmetrical dimer with each subunit having a complete active site. The enzyme-substrate complexes, however, are known to be asymmetrical in solution because the enzyme exhibits half-of-the-sites activity by binding tightly only 1 mol of tyrosine or 1 mol of tyrosyl adenylate per mole of dimer. Evidence is now presented that the unligated enzyme is also asymmetrical in solution. Symmetry was investigated by construction of heterodimers containing one full-length subunit and one truncated subunit, allowing the introduction of different mutations into each monomer. Each dimer is active at only one site, but the site used is randomly distributed between the subunits. Each heterodimer thus consists of two equal populations, one activating tyrosine at a full-length subunit and the other at the truncated subunit. No detectable interconversion is found between active and inactive sites over several minutes either in the absence of substrates or when the enzyme is turning over in the steady state. Kinetic evidence implies that wild-type enzyme is inherently asymmetrical even in the absence of substrate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365365     DOI: 10.1021/bi00403a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  3D-TROSY-based backbone and ILV-methyl resonance assignments of a 319-residue homodimer from a single protein sample.

Authors:  Anna Krejcirikova; Vitali Tugarinov
Journal:  J Biomol NMR       Date:  2012-09-08       Impact factor: 2.835

2.  2.9 A crystal structure of ligand-free tryptophanyl-tRNA synthetase: domain movements fragment the adenine nucleotide binding site.

Authors:  V A Ilyin; B Temple; M Hu; G Li; Y Yin; P Vachette; C W Carter
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

3.  NMR Structure of the C-terminal domain of a tyrosyl-tRNA synthetase that functions in group I intron splicing.

Authors:  Paul J Paukstelis; Nandini Chari; Alan M Lambowitz; David Hoffman
Journal:  Biochemistry       Date:  2011-04-12       Impact factor: 3.162

4.  Asymmetric amino acid activation by class II histidyl-tRNA synthetase from Escherichia coli.

Authors:  Ethan Guth; Mindy Farris; Michael Bovee; Christopher S Francklyn
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

5.  Class I tyrosyl-tRNA synthetase has a class II mode of cognate tRNA recognition.

Authors:  Anna Yaremchuk; Ivan Kriklivyi; Michael Tukalo; Stephen Cusack
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

6.  The two active sites of Thermotoga maritima CheA dimers bind ATP with dramatically different affinities.

Authors:  Anna K Eaton; Richard C Stewart
Journal:  Biochemistry       Date:  2009-07-14       Impact factor: 3.162

7.  Seryl-tRNA synthetase from Escherichia coli: functional evidence for cross-dimer tRNA binding during aminoacylation.

Authors:  C Vincent; F Borel; J C Willison; R Leberman; M Härtlein
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

8.  Structural asymmetry of the terminal catalytic complex in selenocysteine synthesis.

Authors:  Rachel L French; Nirupama Gupta; Paul R Copeland; Miljan Simonović
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

9.  The homotetrameric phosphoseryl-tRNA synthetase from Methanosarcina mazei exhibits half-of-the-sites activity.

Authors:  Scott I Hauenstein; Ya-Ming Hou; John J Perona
Journal:  J Biol Chem       Date:  2008-06-17       Impact factor: 5.157

10.  Catalytic mechanism of the tryptophan activation reaction revealed by crystal structures of human tryptophanyl-tRNA synthetase in different enzymatic states.

Authors:  Ning Shen; Minyu Zhou; Bei Yang; Yadong Yu; Xianchi Dong; Jianping Ding
Journal:  Nucleic Acids Res       Date:  2008-01-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.